Abstract:Recent studies have indicated that autophagy contributes to tumorigenesis and participates in acquired chemotherapeutic resistance. The present study aimed to determine the function and underlying mechanism of cisplatin-induced autophagy in A549 human lung cancer cells. Autophagy was measured by LC3B-I/II conversion, LC3B puncta and autophagosomes formation. Apoptotic cell death was measured by caspase-3 activity, caspase-3 cleavage and LDH release. The transcriptional and expressional level of autophagy related proteins were measured by reverse transcription-quantitative polymerase chain reaction and western blot analysis. Beclin 1 and Atg 5 siRNA transfection was used to explore the function of cisplatin-induced autophagy. The results demonstrated that cisplatin induces apoptotic cell death in A549 cells and triggers an autophagic response, as indicated by increased microtubule-associated protein 1 light chain 3 (LC3B)-I/II conversion, increased LC3B puncta and autophagosome formation. Mechanisms underlying cisplatin-induced autophagic responses were also investigated. Cisplatin induced autophagy by upregulating the mRNA and protein expression levels of autophagy protein (Atg)5 and Beclin 1, whereas the mRNA and protein expression levels of serine/threonine-protein kinase ULK1, Atg3, Atg7, Atg12, and sequestosome-1 were not markedly upregulated. In addition, knockdown of Atg5 and Beclin 1 by small interfering RNA transfection impaired cisplatin-induced activation of autophagic responses, increased caspase-3 cleavage and inhibited cell viability. These findings suggested that disruption of autophagy via the inhibition of Atg5 and Beclin 1 may promote cisplatin-induced apoptotic cell death in A549 human lung cancer cells. In conclusion, the present study demonstrated that targeting autophagy may be used in the future for the treatment of lung cancer.

Cdc34-Mediated Degradation of Atf5 is Blocked by Cisplatin

ATF5 increases cisplatin-induced apoptosis through up-regulation of cyclin D3 transcription in HeLa cells.

Inhibitory Effect of Cisplatin on Proteasome

ATF4/NUPR1 Axis Promotes Cancer Cell Survival and Mediates Immunosuppression in Clear Cell Renal Cell Carcinoma

Inhibition Of Autophagy Promotes Cisplatin-Induced Apoptotic Cell Death Through Atg5 And Beclin 1 In A549 Human Lung Cancer Cells

Cisplatin treatment leads to changes in nuclear protein and microRNA expression

DAP5 ameliorates cisplatin-induced apoptosis of renal tubular cells.

Activating transcription factor 6 contributes to cisplatin‑induced ototoxicity via regulating the unfolded proteins response

TR4 Nuclear Receptor Enhances the Cisplatin Chemo-Sensitivity Via Altering the ATF3 Expression to Better Suppress HCC Cell Growth

Trichostatin A Promotes Cytotoxicity of Cisplatin, as Evidenced by Enhanced Apoptosis/Cell Death Markers

Integrated Global Proteomic and Phosphoproteomic Analysis of Cisplatin-Induced Apoptosis in A549 Cells

Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells.

Phospho-Delta Np63 Alpha-Dependent Regulation Of Autophagic Signaling Through Transcription And Micro-Rna Modulation

Phospho-ΔNp63α-dependent regulation of autophagic signaling through transcription and micro-RNA modulation.

Nuclear proteome analysis of cisplatin-treated HeLa cells

Advancements in Activating Transcription Factor 5 Function in Regulating Cell Stress and Survival

Regulation of PUMA- α by p53 in cisplatin-induced renal cell apoptosis

Receptor of Advanced Glycation End Products Deficiency Attenuates Cisplatin-Induced Acute Nephrotoxicity by Inhibiting Apoptosis, Inflammation and Restoring Fatty Acid Oxidation

Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.

Activation of TFEB-mediated autophagy by trehalose attenuates mitochondrial dysfunction in cisplatin-induced acute kidney injury

BEZ235 reduction of cisplatin resistance on wild-type EGFR non-small cell lung cancer cells